GATA3 and breast carcinoma: Patients with ERα– breast cancers are normally associated with shorter survival times.[75] GATA3 is strongly correlated with ERα expression and both are involved in a cross‐regulatory feedback loop.[54, 76] In this study, we found that CUL4B/NuRD(MTA1) can directly inhibit ERα.